Surprisingly, FGD3 mRNA expression in BT-20, a triple-negative breast cancer cell line, was upregulated to 1.99 and ESR1 was upregulated to 0.47 on a log2 scale when treated with an EGFR inhibitor (Data Supplement).30 The gene discussed is ESR1; the disease is triple-negative breast carcinoma.